Evaluation and comparison of the adverse effects of streptokinase and alteplase.
Pharmacotherapy
; 12(6): 440-4, 1992.
Article
em En
| MEDLINE
| ID: mdl-1492007
ABSTRACT
The frequency and severity of adverse effects resulting from the administration of streptokinase and alteplase were determined in 126 consecutive patients who received standard dosages of these agents for the treatment of acute myocardial infarction. Evaluation was based on patient assessment by nursing staff, physicians, and the investigators before, during, and after thrombolytic administration. Overall, adverse effects occurred in 15 (41.7%) of 36 patients receiving streptokinase and 12 (13.3%) of 90 receiving alteplase (p = 0.001). No major bleeding or neurologic events were documented. Minor bleeding occurred in 13.9% and 7.8% of streptokinase and alteplase recipients, respectively (p = 0.47), and hypotension in 8 (22.2%) and 5 (5.6%), respectively (p = 0.01). The frequency of hypotension associated with streptokinase was significantly higher than that with alteplase. Thrombolytic-induced hypotension was easily managed and was not associated with sequelae.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Estreptoquinase
/
Terapia Trombolítica
/
Ativador de Plasminogênio Tecidual
/
Infarto do Miocárdio
Tipo de estudo:
Clinical_trials
/
Etiology_studies
Limite:
Adult
/
Aged
/
Aged80
/
Humans
/
Middle aged
Idioma:
En
Revista:
Pharmacotherapy
Ano de publicação:
1992
Tipo de documento:
Article